Cause of death, by non-communicable diseases, ages 15-59 in Lithuania
Lithuania: Cause of death, by non-communicable diseases, ages 15-59 was 67.5% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 15-59 in Lithuania, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total deaths ages 15-59.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 15-59 in Lithuania stood at 67.5%.
The figure is down 7.9% on the previous year and down 0.6% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 15-59 in Lithuania peaked at 74.9% in 2019 and was at its lowest, 60.3%, in 2000.
That places Lithuania 45th out of 185 countries with data for 2021, putting it in the top quarter.
Cause of death, by non-communicable diseases, ages 15-59 in Lithuania, year by year
| Year | % of total deaths ages 15-59 | Change |
|---|---|---|
| 2000 | 60.3% | — |
| 2010 | 67.9% | +12.7% |
| 2015 | 72.4% | +6.5% |
| 2019 | 74.9% | +3.5% |
| 2020 | 73.3% | -2.1% |
| 2021 | 67.5% | -7.9% |
Lithuania compared with similar countries
- Lithuania's 67.5% is below the median for high income countries, which is 69.5%, 97% of the median. (58 countries reporting)
- Lithuania's 67.5% is below the median for Europe & Central Asia, which is 68.4%, 99% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 60.3% | 60.3% | 60.3% | 1 |
| 2010s | 71.8% | 67.9% | 74.9% | 3 |
| 2020s | 70.4% | 67.5% | 73.3% | 2 |
Countries ranked near Lithuania
More health data for Lithuania
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.4537 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,909 deaths per 1,000 people (2090)
- Number of infants who die before age 1 5 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -4.51 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0199 units per person (2025)
- Population ages 00-04, male, annual growth rate -4.59 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 15-59 in Lithuania?
- Cause of death, by non-communicable diseases, ages 15-59 in Lithuania was 67.5% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 15-59 recorded in Lithuania?
- The highest recorded value was 74.9% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 15-59 recorded in Lithuania?
- The lowest recorded value was 60.3% in 2000.
- How does Lithuania rank for cause of death, by non-communicable diseases, ages 15-59?
- Lithuania ranks 45th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 15-59 rising or falling in Lithuania?
- Over the last ten years it is down 0.6%. The long-run trend across the full record is rising.
- Where does this Lithuania data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.